Please use this identifier to cite or link to this item:
https://hdl.handle.net/11147/14768
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ulu,G.T. | - |
dc.contributor.author | Kiraz,Y. | - |
dc.contributor.author | Baran,Y. | - |
dc.date.accessioned | 2024-09-24T15:54:17Z | - |
dc.date.available | 2024-09-24T15:54:17Z | - |
dc.date.issued | 2020 | - |
dc.identifier.isbn | 978-012819541-3 | - |
dc.identifier.uri | https://doi.org/10.1016/B978-0-12-819541-3.00022-0 | - |
dc.identifier.uri | https://hdl.handle.net/11147/14768 | - |
dc.description.abstract | What images are coming to your mind when you think about sustainable and qualified life? The main picture drawn is healthcare. Many people suffer from cancer; more than 18.1 million people were diagnosed with cancer and 9.6 million people died from cancer worldwide in 2018. Therefore many diagnosis and treatment strategies that are shaped and regulated by biomedicine approaches have been developed to solve this problem. Biomedicine is an interdisciplinary science to understand the interaction of biological, chemical, and physiological principles. These principles should be brought together to be applicable and sustainable for qualified life. Drug discovery and combination therapy using nanocarriers and natural compounds are being innovated as new approaches and opportunities for cancer treatment. Theoretically and practically, there is no limit to the development of new biomedicinal tools for personalized medicine in cancer. Therefore personalized medicine plays an important role for reaching successful therapy with low cost. By discovering the diverse potential of biomedicine, we can provide better healthcare in the world. © 2020 Elsevier Inc. All rights reserved. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.ispartof | Biodiversity and Biomedicine: Our Future | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Biomedicine | en_US |
dc.subject | Cancer | en_US |
dc.subject | Drug discovery | en_US |
dc.subject | Personalized therapy | en_US |
dc.title | Personalized biomedicine in cancer: From traditional therapy to sustainable healthcare | en_US |
dc.type | Book Part | en_US |
dc.department | Izmir Institute of Technology | en_US |
dc.identifier.startpage | 441 | en_US |
dc.identifier.endpage | 457 | en_US |
dc.identifier.scopus | 2-s2.0-85147597451 | - |
dc.relation.publicationcategory | Kitap Bölümü - Uluslararası | en_US |
dc.identifier.doi | 10.1016/B978-0-12-819541-3.00022-0 | - |
dc.authorscopusid | 57215384419 | - |
dc.authorscopusid | 56422406900 | - |
dc.authorscopusid | 9636164400 | - |
dc.identifier.wosquality | N/A | - |
dc.identifier.scopusquality | N/A | - |
item.fulltext | No Fulltext | - |
item.grantfulltext | none | - |
item.languageiso639-1 | en | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
item.openairetype | Book Part | - |
Appears in Collections: | Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection |
CORE Recommender
SCOPUSTM
Citations
2
checked on Nov 15, 2024
Page view(s)
12
checked on Nov 18, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.